Menu
Recruiting NCT06600542

Inari VISION Registry

Observational Pulmonary Embolism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Inari Medical Commercially Available Devices.
Who it may be relevant to
Registry conditions: Pulmonary Embolism. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy, Portugal, United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Interventions

  • Device Inari Medical Commercially Available Devices
    Commercially approved Inari Medical devices

Primary outcome measures

  • Incidence of device-related, procedure-related, or fatal Adverse Events [Time frame: Up to 180 days]

Eligibility criteria

Inclusion criteria

  • Willing and able to provide informed consent per institution and geographical requirements
  • Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
  • Currently within enrollment window relative to their procedure
  • Age ≥ 18 years

Exclusion criteria

  • Is or will be inaccessible for registry follow-up
  • Meets exclusion criteria required by local requirements
  • Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
  • Is pregnant or breastfeeding at the time of enrollment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United Kingdom · 8 centers
  • Southmead Hospital Bristol — Bristol
  • Queen Elizabeth University Hospital — Glasgow
  • Northwick Park Hospital — London
  • Royal Free Hospital — London
  • Royal London — London
  • UCLH University College London Hospital — London
  • Royal Victoria Infirmary — Newcastle
  • Great Western Hospital — Swindon
Italy · 1 center
  • Azienda Ospedaliero Universitaria delle Marche — Ancona
Portugal · 1 center
  • Santa Marta Hospital — Lisbon

Identifiers

NCT: NCT06600542 · 24-003

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗